Triiodothyronine is a potent agonist of both thyroid hormone receptors TRα and Trβ with Kis of 2.3 nM for both. Triiodothyronine (0.01-0.1 μM) results in a decrease in the TRalpha1:TRalpha2 mRNA ratio in HepG2 cells.
|Body Surface Area (m2)||0.007||0.025||0.15||0.05||0.02||0.5|
|Animal A (mg/kg) = Animal B (mg/kg) multiplied by||Animal B Km|
|Animal A Km|
For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.
|Solubility||DMSO 6 mg/mL|
Triiodothyronine affects the alternative splicing of thyroid hormone receptor alpha mRNA.
Timmer DC, et al. J Endocrinol. 2003 Nov;179(2):217-25. PMID: 14596673.
Increased sensitivity to thyroid hormone in mice with complete deficiency of thyroid hormone receptor alpha.
Macchia PE, et al. Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):349-54. PMID: 11120878.
|2-Chloro-5- nitro-benzeneacetic acid|
FX1 is a potent and specific BCL6 inhibitor, with an IC50 of around 35 μM.
GC376 is a 3CLpro inhibitor; inhibits the replication of viruses TGEV, FIPV and PTV with IC50 values of 0.15, 0.2 and 0.15 μM.
AVex-73 hydrochloride is a Sigma-1 Receptor agonist with an IC50 of 860 nM.
Tropifexor is a novel and highly potent agonist of farnesoid X receptor (FXR).
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2017 AbMole BioScience. All Rights Reserved.